Thrivent Financial for Lutherans Sells 236,009 Shares of Humana Inc. $HUM

Thrivent Financial for Lutherans reduced its stake in shares of Humana Inc. (NYSE:HUM) by 93.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,217 shares of the insurance provider’s stock after selling 236,009 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Humana were worth $4,210,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HUM. Vanguard Group Inc. grew its holdings in Humana by 1.6% during the second quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider’s stock valued at $3,471,395,000 after purchasing an additional 226,224 shares during the period. Dodge & Cox grew its holdings in shares of Humana by 5.6% in the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after buying an additional 597,705 shares during the period. State Street Corp increased its position in shares of Humana by 1.1% in the 2nd quarter. State Street Corp now owns 5,377,390 shares of the insurance provider’s stock valued at $1,319,334,000 after buying an additional 58,094 shares in the last quarter. Pzena Investment Management LLC increased its position in shares of Humana by 6.5% in the 2nd quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock valued at $996,664,000 after buying an additional 247,744 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Humana by 1.9% during the 2nd quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider’s stock worth $762,233,000 after buying an additional 57,267 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of HUM opened at $259.70 on Friday. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35. The stock has a market capitalization of $31.23 billion, a P/E ratio of 24.34, a P/E/G ratio of 1.52 and a beta of 0.46. The company has a 50 day moving average of $259.48 and a 200-day moving average of $259.40.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the prior year, the company posted $4.16 earnings per share. The firm’s revenue was up 11.1% on a year-over-year basis. As a group, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Guggenheim reiterated a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Evercore ISI started coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Sanford C. Bernstein lifted their price target on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Finally, Truist Financial reduced their price target on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Nine research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $294.32.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.